Drawing for PHIRESIDE

USPTO serial 97908749

PHIRESIDE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
LEASER, ANDREW C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHIRESIDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory S. Bernabeo

Gregory S. Bernabeo FISHERBROYLES LLP1650 MARKET STREETONE LIBERTY PLACE, 36TH FLOORPHILADELPHIA, PA 19102

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software featuring financial, travel, medication compliance, and clinical trial participation information relevant to clinical trial participants; Downloadable software for providing clinical trial participants access to information relating to payments for participation in clinical trials; Downloadable software featuring information relevant to travel itineraries and travel arrangements associated with participation in clinical trials; Downloadable software providing access to medication information and clinical trial participant surveysACTIVE—
036Providing an Internet website portal featuring financial information relevant to clinical trial participants; Providing an Internet website portal for clinical trial participants featuring financial information relating to payments for participation in clinical trialsACTIVE—
039Providing an Internet website portal featuring travel information relevant to clinical trial participants; Providing an Internet website portal featuring information relevant to travel itineraries and travel arrangements associated with participation in clinical trialsACTIVE—
042Providing an Internet website portal featuring technology that enables clinical trial participants to access information relating to payments for participation in clinical trials; Providing an Internet website portal featuring technology that enables users to access medication information and participate in surveys regarding their participation in clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 10, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 10, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 6, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 11, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 11, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 22, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 23, 2024DOCKASSIGNED TO EXAMINER—
May 24, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 1, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance